Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center Assessment of Survivors for Kidney Disease After COVID-19

NCT05328986 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.

NCT NCT05328986
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05328986 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center Assessment of Survivors for Kidney Disease After COVID-19
Lead sponsor
Icahn School of Medicine at Mount Sinai
Phase
Observational
Overall status
Completed
Start date
January 4, 2020
Completion date
January 4, 2024
Enrollment
1,753 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, chronic kidney injury, covid-19